LeanTaaS is a software company that uses lean principles, machine learning, and predictive analytics to digitally transform core operational processes in healthcare. This transformation increases patient access, decreases wait times, improves staff satisfaction, reduces healthcare delivery costs, and improves operational performance. LeanTaaS's cloud-based iQueue platform mathematically matches the demand for expensive, constrained healthcare resources – operating rooms, infusion chairs, imaging assets, inpatient beds, etc.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech

VIAL ANNOUNCES STRATEGIC PARTNERSHIP TO BUILD CFR PART 11 OPEN SOURCE E-SIGNATURE PLATFORM WITH DOCUMENSO

PRNewswire | August 24, 2023

news image

Vial, a global tech-driven CRO providing next-generation clinical trial management services, has announced a partnership with Documenso, an innovative open-source digital signing platform. The collaboration marks a significant step forward in revolutionizing document signing practices within the life science sector, providing a compelling alternative to traditional solutions like DocuSign. In an era where digital transformation is reshaping industries, Vial's partnership wit...

Read More

Medical

ARUNA BIO ADVANCES THERAPEUTIC DEVELOPMENT FOR TRAUMATIC BRAIN INJURY

Aruna Bio | June 01, 2022

news image

Aruna Bio, Inc., a leader in the development of neural exosome based therapeutics for the treatment of neurodegenerative diseases, today announced that it has received funding from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health of Health to advance AB126™, a multimodal neuroprotective and regenerative neural stem cell extracellular vesicle (NSC EV) product, to treat Traumatic Brain Injury (TBI). The succ...

Read More

Medical, Industry Outlook

REGENXBIO ANNOUNCES NAV® TECHNOLOGY PLATFORM WILL SUPPORT BESPOKE GENE THERAPY CONSORTIUM'S FIRST RARE DISEASE CLINICAL PORTFOLIO

PRNewswire | May 17, 2023

news image

REGENXBIO Inc. announced that preclinical research in Mucopolysaccharidosis type IVA also known as Morquio syndrome, was selected for inclusion in the Foundation for the National Institutes of Health Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC), clinical trial portfolio. The Consortium brings together partners such as NIH and FDA, as well as partners from private and non-profit sectors. Sponsored by Nemours Children's Hospital, MPS ...

Read More

BGN TECHNOLOGIES ANNOUNCES RESEARCH COLLABORATION AGREEMENT WITH ECOIBÉRIA IN THE FIELD OF PLASTIC RECYCLING BY BACTERIA

BGN Technologies | November 05, 2020

news image

BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), announced today that it had signed a research collaboration agreement with ECOIBÉRIA in the field of plastic recycling by bacteria, based on research from the team of Prof. Ariel Kushmaro and Prof. Alex Sivan, both from the Laboratory of Environmental Biotechnology and Avram and Stella Goldstein-Goren Department of Biotechnology Engineering at BGU. Polyethylene terephthalate (PET) is the most ab...

Read More
news image

MedTech

VIAL ANNOUNCES STRATEGIC PARTNERSHIP TO BUILD CFR PART 11 OPEN SOURCE E-SIGNATURE PLATFORM WITH DOCUMENSO

PRNewswire | August 24, 2023

Vial, a global tech-driven CRO providing next-generation clinical trial management services, has announced a partnership with Documenso, an innovative open-source digital signing platform. The collaboration marks a significant step forward in revolutionizing document signing practices within the life science sector, providing a compelling alternative to traditional solutions like DocuSign. In an era where digital transformation is reshaping industries, Vial's partnership wit...

Read More
news image

Medical

ARUNA BIO ADVANCES THERAPEUTIC DEVELOPMENT FOR TRAUMATIC BRAIN INJURY

Aruna Bio | June 01, 2022

Aruna Bio, Inc., a leader in the development of neural exosome based therapeutics for the treatment of neurodegenerative diseases, today announced that it has received funding from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health of Health to advance AB126™, a multimodal neuroprotective and regenerative neural stem cell extracellular vesicle (NSC EV) product, to treat Traumatic Brain Injury (TBI). The succ...

Read More
news image

Medical, Industry Outlook

REGENXBIO ANNOUNCES NAV® TECHNOLOGY PLATFORM WILL SUPPORT BESPOKE GENE THERAPY CONSORTIUM'S FIRST RARE DISEASE CLINICAL PORTFOLIO

PRNewswire | May 17, 2023

REGENXBIO Inc. announced that preclinical research in Mucopolysaccharidosis type IVA also known as Morquio syndrome, was selected for inclusion in the Foundation for the National Institutes of Health Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC), clinical trial portfolio. The Consortium brings together partners such as NIH and FDA, as well as partners from private and non-profit sectors. Sponsored by Nemours Children's Hospital, MPS ...

Read More
news image

BGN TECHNOLOGIES ANNOUNCES RESEARCH COLLABORATION AGREEMENT WITH ECOIBÉRIA IN THE FIELD OF PLASTIC RECYCLING BY BACTERIA

BGN Technologies | November 05, 2020

BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), announced today that it had signed a research collaboration agreement with ECOIBÉRIA in the field of plastic recycling by bacteria, based on research from the team of Prof. Ariel Kushmaro and Prof. Alex Sivan, both from the Laboratory of Environmental Biotechnology and Avram and Stella Goldstein-Goren Department of Biotechnology Engineering at BGU. Polyethylene terephthalate (PET) is the most ab...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us